Maximus, Inc. (MMS) Shares Bought by First Trust Advisors LP

First Trust Advisors LP grew its holdings in Maximus, Inc. (NYSE:MMS) by 14.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 29,486 shares of the health services provider’s stock after purchasing an additional 3,680 shares during the quarter. First Trust Advisors LP’s holdings in Maximus were worth $1,847,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the company. Arizona State Retirement System grew its position in shares of Maximus by 1.1% in the second quarter. Arizona State Retirement System now owns 27,300 shares of the health services provider’s stock valued at $1,710,000 after purchasing an additional 300 shares during the last quarter. Boston Partners grew its position in shares of Maximus by 3.4% in the second quarter. Boston Partners now owns 457,176 shares of the health services provider’s stock valued at $28,633,000 after purchasing an additional 15,164 shares during the last quarter. Schwab Charles Investment Management Inc. grew its position in shares of Maximus by 13.9% in the second quarter. Schwab Charles Investment Management Inc. now owns 495,589 shares of the health services provider’s stock valued at $31,039,000 after purchasing an additional 60,320 shares during the last quarter. First Bank & Trust grew its position in shares of Maximus by 4.2% in the second quarter. First Bank & Trust now owns 2,507 shares of the health services provider’s stock valued at $157,000 after purchasing an additional 101 shares during the last quarter. Finally, Sei Investments Co. grew its position in shares of Maximus by 941.9% in the second quarter. Sei Investments Co. now owns 47,240 shares of the health services provider’s stock valued at $2,958,000 after purchasing an additional 42,706 shares during the last quarter. 97.23% of the stock is currently owned by institutional investors.

Shares of Maximus, Inc. (NYSE:MMS) opened at 63.51 on Wednesday. Maximus, Inc. has a 1-year low of $43.69 and a 1-year high of $64.97. The company has a market cap of $4.12 billion, a PE ratio of 20.36 and a beta of 1.37. The company has a 50 day moving average of $60.45 and a 200 day moving average of $61.38.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business had revenue of $600.40 million for the quarter, compared to analyst estimates of $614.12 million. During the same quarter in the prior year, the business earned $0.79 EPS. Maximus’s quarterly revenue was down 2.7% on a year-over-year basis. Equities analysts expect that Maximus, Inc. will post $3.13 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Thursday, August 31st. Investors of record on Tuesday, August 15th were paid a $0.045 dividend. The ex-dividend date of this dividend was Friday, August 11th. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. Maximus’s dividend payout ratio (DPR) is currently 5.73%.

Several equities research analysts have recently issued reports on the company. Robert W. Baird assumed coverage on Maximus in a research report on Sunday, September 3rd. They issued a “neutral” rating on the stock. Zacks Investment Research cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Maxim Group set a $66.00 target price on shares of Maximus and gave the company a “hold” rating in a research note on Thursday, August 3rd. BidaskClub cut shares of Maximus from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Finally, Canaccord Genuity cut shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research note on Tuesday, July 4th. One analyst has rated the stock with a sell rating and nine have assigned a hold rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $62.43.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/09/13/maximus-inc-mms-shares-bought-by-first-trust-advisors-lp.html.

In related news, General Counsel David Francis sold 1,000 shares of the company’s stock in a transaction dated Friday, June 23rd. The shares were sold at an average price of $63.15, for a total value of $63,150.00. Following the transaction, the general counsel now owns 16,715 shares in the company, valued at approximately $1,055,552.25. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, President Bruce Caswell sold 8,000 shares of the company’s stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $63.56, for a total transaction of $508,480.00. Following the completion of the transaction, the president now owns 35,904 shares in the company, valued at approximately $2,282,058.24. The disclosure for this sale can be found here. In the last quarter, insiders sold 133,403 shares of company stock worth $8,153,731. 3.10% of the stock is owned by company insiders.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply